Back
NovaBay Pharmaceuticals Vs. Twilio Industry Stock Comparison
Sell
29
NBY
NovaBay Pharmaceuticals
Last Price:
$0.59
Seasonality Move:
-8.66%
Buy
62
TWLO
Twilio
Last Price:
$95.69
Seasonality Move:
24.45%
Sell
29
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.58. The Score for NBY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.58The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
TWLO Stock Price Chart
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 50.73 | Buy |
Chaikin Money Flow: | 1879 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.53 - 0.61) | Buy |
Bollinger Bands (100): | (0.55 - 0.67) | Sell |
TWLO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.91 | Sell |
Relative Strength Index (14 RSI): | 52.3 | Buy |
Chaikin Money Flow: | 1083506 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (84.18 - 100.34) | Buy |
Bollinger Bands (100): | (93.6 - 128.36) | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.59 | Sell |
20-day SMA: | 0.56 | Buy |
50-day SMA: | 0.6 | Sell |
200-day SMA: | 0.72 | Sell |
8-day EMA: | 0.58 | Buy |
20-day EMA: | 0.57 | Buy |
50-day EMA: | 0.59 | Sell |
200-day EMA: | 2.41 | Sell |
TWLO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 87.53 | Buy |
20-day SMA: | 89.24 | Buy |
50-day SMA: | 103.63 | Sell |
200-day SMA: | 89.6 | Buy |
8-day EMA: | 89.2 | Buy |
20-day EMA: | 91.02 | Buy |
50-day EMA: | 99.52 | Sell |
200-day EMA: | 93.69 | Buy |
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Twilio Earnings Growth & TWLO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.76 per share.
NovaBay Pharmaceuticals Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Twilio Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |